Boostrix is a vaccine for children, adults, and the elderly. It is a combination vaccine used to provide protection against three serious diseases: tetanus, diphtheria, and acellular pertussis.

Benefits of BOOSTRIX
This vaccine helps prevent Tetanus, Diphtheria, and Pertussis (Whooping Cough).

Diphtheria and pertussis are transmitted through respiratory droplets, while tetanus enters the body through dirty or contaminated open wounds.

Tetanus can cause severe muscle stiffness and pain, inability to open the mouth (lockjaw), difficulty swallowing, and breathing problems.

Diphtheria may lead to breathing difficulties, heart failure, paralysis, and is often characterized by a grayish membrane covering the throat.

Pertussis (Whooping Cough) causes prolonged, severe coughing accompanied by a high-pitched “whoop” sound when inhaling, making breathing difficult. Symptoms may last for weeks.

In infants, pertussis can result in pneumonia, seizures, brain damage, and even death.

In adults, severe coughing may cause rib fractures.

BOOSTRIX Vaccination Schedule

Vaccination Schedule for Children
Tdap vaccine: 1 dose starting at 7 years of age

Vaccination Schedule for Adults
Tdap vaccine: 1 dose, with a booster every 10 years
Pregnant women: recommended during 27–36 weeks of pregnancy

Vaccination Schedule for the Elderly
Tdap vaccine: 1 dose, with a booster every 10 years

Composition of BOOSTRIX Vaccine

Each 0.5 ml dose contains:
Diphtheria toxoid, Tetanus toxoid, Bordetella pertussis antigens (Pertussis toxoid, Filamentous hemagglutinin,Pertactin) and Aluminum hydroxide hydrate, Aluminum phosphate

Side Effects of BOOSTRIX Vaccine

In children:
Fever, irritability, drowsiness, nausea, vomiting, digestive discomfort, and redness, swelling, or pain at the injection site.

In adults:
Headache, nausea, and redness, swelling, or pain at the injection site.

Contraindication of BOOSTRIX Vaccine

Hypersensitivity to any vaccine component

History of severe allergic reaction to previous Tdap vaccination

History of coma, decreased consciousness, or seizures within 7 days after receiving DTaP or Tdap

History of thrombocytopenia or neurological complications following DTaP or Tdap vaccination